Figure 3.
Right upper lobe mass, NSCLC. (A) Pre-treatment contrast-enhanced CT; (B) contrast-enhanced CT 8 weeks later after treatment, the efficacy evaluation was progression (PD); (C) kurtosis map; (D) S(1,0) SumEntrp map; (E) S(2,2) SumEntrp map.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.